Amarantus BioScience (AMBS) Short Interest Ratio & Short Volume

Short interest is the volume of Amarantus BioScience shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 31,200 shares of AMBS short. Learn More on Amarantus BioScience's current short interest.

Amarantus BioScience saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 31,200 shares, a decline of 64.9% from the previous total of 89,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Amarantus BioScience: Propanc Biopharma, Inc. (0.01%), RegeneRx Biopharmaceuticals, Inc. (0.01%), Adhera Therapeutics, Inc. (0.00%), Predictive Technology Group, Inc. (0.00%), Acura Pharmaceuticals, Inc. (0.01%), ReNeuron Group plc (0.00%), CVR Medical Corp. (0.03%), Bruush Oral Care Inc. (62.06%), Oncology Pharma Inc. (0.03%), and Todos Medical Ltd. (0.07%).

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling AMBS is an investing strategy that aims to generate trading profit from Amarantus BioScience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Amarantus BioScience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMBS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMBS, twice per month. The most recent reporting period available is January, 15 2024.